Although KCs and HSCs both respond to TLR2 ligands, TLR2 bone marrow chimeric mice demonstrated that KCs play a greater role in the TLR2-mediated progression of NASH than HSCs (112). The gene discussed is TLR2; the disease is metabolic dysfunction-associated steatohepatitis.